EBOS Group Limited/Announcement
EBOS Group Limited logo

Notification of allotment of securities – DRP shares

Capital Change5 April 2019EBOHealthcare

EBOS Group Limited. NZBN 9429031998840
Level 7, 737 Bourke Street, Docklands, Victoria 3008, Australia. PO Box 7300, Melbourne, Victoria 8004, Australia.

Phone: +61 3 9918 5555, Fax: +61 3 9918 5599.

www.ebosgroup.com




5 April 2019

NZX/ASX Code: EBO


EBOS GROUP LIMITED – NOTIFICATION OF ALLOTMENT OF SECURITIES

For the purposes of Listing Rule 7.12.1 and further to the Appendix 7 lodged by the Company on

20 February 2019, EBOS Group Limited advises the following securities have been issued:

Class of securities issued Ordinary Shares

ISIN NZEBOE0001S6

Number of securities issued 285,568 Ordinary Shares

Issue Price NZ$21.12

Payment terms In lieu of dividend

Amount paid up Fully paid

Percentage of total class issued (excluding

treasury stock)

0.18686% of Ordinary Shares

Reason for issue

Issue of Ordinary Shares to those

shareholders who have elected to

participate in the Dividend Reinvestment

Plan for the interim dividend

Specific authority for the issue Directors’ resolution

Terms or details of the issue

Issue of 285,568 Ordinary Shares pursuant

to the terms of the Dividend Reinvestment

Plan Offer document dated 26 August 2014

Total number of securities in existence

after issue

152,824,872

Date of issue 5 April 2019


Janelle Cain

General Counsel

EBOS Group Limited

---

Appendix 3B
New issue announcement




+ See chapter 19 for defined terms.


04/03/2013 Appendix 3B Page 1

Rule 2.7, 3.10.3, 3.10.4, 3.10.5

Appendix 3B


New issue announcement,

application for quotation of additional securities

and agreement


Information or documents not available now must be given to ASX as soon as available. Information and

documents given to ASX become ASX’s property and may be made public.

Introduced 01/07/96 Origin: Appendix 5 Amended 01/07/98, 01/09/99, 01/07/00, 30/09/01, 11/03/02, 01/01/03, 24/10/05, 01/08/12,

04/03/13



Name of entity

EBOS Group Limited


ABN

N/A


We (the entity) give ASX the following information.



Part 1 - All issues

You must complete the relevant sections (attach sheets if there is not enough space).


1

+

Class of

+

securities issued or to

be issued


Fully paid ordinary shares



2 Number of

+

securities issued or

to be issued (if known) or

maximum number which may

be issued


285,568



3 Principal terms of the

+

securities (e.g. if options,

exercise price and expiry date; if

partly paid

+

securities, the

amount outstanding and due

dates for payment; if

+

convertible securities, the

conversion price and dates for

conversion)


The shares were issued with the same rights

and liabilities as existing shares.

Appendix 3B
New issue announcement




+ See chapter 19 for defined terms.


Appendix 3B Page 2 04/03/2013



4 Do the

+

securities rank equally

in all respects from the

+

issue

date with an existing

+

class of

quoted

+

securities?


If the additional

+

securities do

not rank equally, please state:

 the date from which they do

 the extent to which they

participate for the next

dividend, (in the case of a

trust, distribution) or

interest payment

 the extent to which they do

not rank equally, other than

in relation to the next

dividend, distribution or

interest payment

Yes, the shares rank equally with existing

ordinary shares.




5 Issue price or consideration


NZ$21.12



6 Purpose of the issue

(If issued as consideration for

the acquisition of assets, clearly

identify those assets)







Issue to participants in the Company’s

dividend reinvestment plan in respect of the

interim dividend.



6a Is the entity an

+

eligible entity

that has obtained security

holder approval under rule 7.1A?


If Yes, complete sections 6b – 6h

in relation to the

+

securities the

subject of this Appendix 3B, and

comply with section 6i

No.



6b The date the security holder

resolution under rule 7.1A was

passed

N/A



6c Number of

+

securities issued

without security holder approval

under rule 7.1

N/A


Appendix 3B
New issue announcement




+ See chapter 19 for defined terms.


04/03/2013 Appendix 3B Page 3

6d Number of

+

securities issued

with security holder approval

under rule 7.1A

N/A



6e Number of

+

securities issued

with security holder approval

under rule 7.3, or another

specific security holder approval

(specify date of meeting)


N/A



6f Number of

+

securities issued

under an exception in rule 7.2

N/A



6g If

+

securities issued under rule

7.1A, was issue price at least 75%

of 15 day VWAP as calculated

under rule 7.1A.3? Include the

+

issue date and both values.

Include the source of the VWAP

calculation.

N/A



6h If

+

securities were issued under

rule 7.1A for non-cash

consideration, state date on

which valuation of

consideration was released to

ASX Market Announcements

N/A



6i Calculate the entity’s remaining

issue capacity under rule 7.1 and

rule 7.1A – complete Annexure 1

and release to ASX Market

Announcements

N/A



7

+

Issue dates

Note: The issue date may be prescribed by

ASX (refer to the definition of issue date in

rule 19.12). For example, the issue date for a

pro rata entitlement issue must comply with

the applicable timetable in Appendix 7A.

Cross reference: item 33 of Appendix 3B.

5 April 2019




Number

+

Class

8 Number and

+

class of all

+

securities quoted on ASX

(including the

+

securities in

section 2 if applicable)




152,824,872 Fully paid ordinary

shares


Appendix 3B
New issue announcement




+ See chapter 19 for defined terms.


Appendix 3B Page 4 04/03/2013



Number

+

Class

9 Number and

+

class of all

+

securities not quoted on ASX

(including the

+

securities in

section 2 if applicable)




180,300 Performance Rights

(unquoted)



10 Dividend policy (in the case of a

trust, distribution policy) on the

increased capital (interests)

The dividend policy for all ordinary shares is

as determined by the EBOS Board from time

to time.




Part 2 - Pro rata issue


11 Is security holder approval

required?


N/A



12 Is the issue renounceable or non-

renounceable?

N/A



13 Ratio in which the

+

securities

will be offered

N/A



14

+

Class of

+

securities to which the

offer relates

N/A



15

+

Record date to determine

entitlements

N/A



16 Will holdings on different

registers (or subregisters) be

aggregated for calculating

entitlements?

N/A



17 Policy for deciding entitlements

in relation to fractions


N/A



18 Names of countries in which the

entity has security holders who

will not be sent new offer

documents

Note: Security holders must be told how their

entitlements are to be dealt with.

Cross reference: rule 7.7.

N/A

Appendix 3B
New issue announcement




+ See chapter 19 for defined terms.


04/03/2013 Appendix 3B Page 5

19 Closing date for receipt of

acceptances or renunciations

N/A

Appendix 3B
New issue announcement




+ See chapter 19 for defined terms.


Appendix 3B Page 6 04/03/2013


20 Names of any underwriters



N/A



21 Amount of any underwriting fee

or commission

N/A



22 Names of any brokers to the

issue



N/A



23 Fee or commission payable to the

broker to the issue

N/A



24 Amount of any handling fee

payable to brokers who lodge

acceptances or renunciations on

behalf of security holders

N/A



25 If the issue is contingent on

security holders’ approval, the

date of the meeting

N/A



26 Date entitlement and acceptance

form and offer documents will be

sent to persons entitled

N/A



27 If the entity has issued options,

and the terms entitle option

holders to participate on

exercise, the date on which

notices will be sent to option

holders

N/A



28 Date rights trading will begin (if

applicable)

N/A



29 Date rights trading will end (if

applicable)



N/A



30 How do security holders sell

their entitlements in full through

a broker?

N/A



31 How do security holders sell part

of their entitlements through a

broker and accept for the

balance?

N/A


Appendix 3B
New issue announcement




+ See chapter 19 for defined terms.


04/03/2013 Appendix 3B Page 7


32 How do security holders dispose

of their entitlements (except by

sale through a broker)?

N/A



33

+

Issue date



N/A



Part 3 - Quotation of securities

You need only complete this section if you are applying for quotation of securities


34 Type of

+

securities

(tick one)


(a)


+

Securities described in Part 1



(b)


All other

+

securities

Example: restricted securities at the end of the escrowed period, partly paid securities that become fully paid,

employee incentive share securities when restriction ends, securities issued on expiry or conversion of convertible

securities


Entities that have ticked box 34(a)


Additional securities forming a new class of securities



Tick to indicate you are providing the information or

documents



35


If the

+

securities are

+

equity securities, the names of the 20 largest holders of the

additional

+

securities, and the number and percentage of additional

+

securities

held by those holders



36


If the

+

securities are

+

equity securities, a distribution schedule of the additional

+

securities setting out the number of holders in the categories

1 - 1,000

1,001 - 5,000

5,001 - 10,000

10,001 - 100,000

100,001 and over



37


A copy of any trust deed for the additional

+

securities

Appendix 3B
New issue announcement




+ See chapter 19 for defined terms.


Appendix 3B Page 8 04/03/2013


Entities that have ticked box 34(b)


38 Number of

+

securities for which

+

quotation is sought






39

+

Class of

+

securities for which

quotation is sought





40 Do the

+

securities rank equally in

all respects from the

+

issue date

with an existing

+

class of quoted

+

securities?


If the additional

+

securities do not

rank equally, please state:

 the date from which they do

 the extent to which they

participate for the next

dividend, (in the case of a

trust, distribution) or interest

payment

 the extent to which they do

not rank equally, other than in

relation to the next dividend,

distribution or interest

payment




41 Reason for request for quotation

now

Example: In the case of restricted securities, end

of restriction period


(if issued upon conversion of

another

+

security, clearly identify

that other

+

security)






Number

+

Class

42 Number and

+

class of all

+

securities quoted on ASX

(including the

+

securities in clause

38)






Appendix 3B
New issue announcement




+ See chapter 19 for defined terms.


04/03/2013 Appendix 3B Page 9



Quotation agreement


1

+

Quotation of our additional

+

securities is in ASX’s absolute discretion. ASX

may quote the

+

securities on any conditions it decides.


2 We warrant the following to ASX.


 The issue of the

+

securities to be quoted complies with the law and is

not for an illegal purpose.


 There is no reason why those

+

securities should not be granted

+

quotation.


 An offer of the

+

securities for sale within 12 months after their issue

will not require disclosure under section 707(3) or section 1012C(6) of

the Corporations Act.

Note: An entity may need to obtain appropriate warranties from subscribers for the securities in order to be

able to give this warranty


 Section 724 or section 1016E of the Corporations Act does not apply to

any applications received by us in relation to any

+

securities to be

quoted and that no-one has any right to return any

+

securities to be

quoted under sections 737, 738 or 1016F of the Corporations Act at the

time that we request that the

+

securities be quoted.


 If we are a trust, we warrant that no person has the right to return the

+

securities to be quoted under section 1019B of the Corporations Act at

the time that we request that the

+

securities be quoted.


3 We will indemnify ASX to the fullest extent permitted by law in respect of any

claim, action or expense arising from or connected with any breach of the

warranties in this agreement.


4 We give ASX the information and documents required by this form. If any

information or document is not available now, we will give it to ASX before

+

quotation of the

+

securities begins. We acknowledge that ASX is relying on

the information and documents. We warrant that they are (will be) true and

complete.



Sign here: ............................................................ Date: 5 April 2019

(General Counsel)



Print name: Janelle Cain

Data sourced from publicly available filings. Our datasets may not be complete. Automated analysis can produce errors. If you believe any data on this page is incorrect, please contact us at hello@nzxplorer.co.nz. For informational purposes only. Not investment advice.

Other issuers discussed similar conditions around this time

Matched by meaning across NZX announcement text, not keywords — based on our semantic index of announcement bodies.

  • ANZ — ANZ Group Holdings Limited: Appendix 3B
    2019-07-02

    Appendix 3B New issue announcement + See chapter 19 for defined terms. 04/03/2013 Appendix 3B Page 1 29390304_3 Rule 2.7, 3.10.3, 3.10.4, 3.10.5 Appendix 3B New issue announcement, application for quotation of additional securities and agreement Information…”

  • ATM — The a2 Milk Company Limited: Capital Change Notice
    2019-06-30

    Appendix 3B New issue announcement + See chapter 19 for defined terms. 04/03/2013 Appendix 3B Page 3 6d Number of + securities issued with security holder approval under rule 7.1A n/a 6e Number of + securities issued with security holder app…”

  • FPH — Fisher & Paykel Healthcare Corporation Limited: Notification of Issue of Securities
    2019-07-01

    + See chapter 19 for defined terms. 04/03/2013 Appendix 3B Page 1 Rule 2.7, 3.10.3, 3.10.4, 3.10.5 Appendix 3B New issue announcement, application for quotation of additional securities and agreement Information or documents not available now must be given t…”